๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics of a single dose of ofloxacin in healthy elderly subjects using noncompartmental and compartmental models

โœ Scribed by Rademaker, C. M. A. ;Jones, R. W. ;Notarianni, L. J. ;van Dijk, A. ;Glerum, J. H. ;Verhoef, J.

Publisher
Springer
Year
1989
Tongue
Dutch
Weight
447 KB
Volume
11
Category
Article
ISSN
1573-739X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Single and multiple dose pharmacokinetic
Single and multiple dose pharmacokinetics of etizolam in healthy subjects
โœ C. Fracasso; S. Confalonieri; S. Garattini; S. Caccia ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 498 KB

The pharmacokinetics of etizolam, a new thienodiazepine derivative, has been examined after single and multiple (0.5 mg tablet) (0.5 mg b.d for 1 week) oral therapeutic doses in healthy volunteers. The single-dose kinetic profile of etizolam suggested that absorption after oral dosage was reasonably

Single-dose pharmacokinetics of nefazodo
Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment
โœ R. H. Barbhaiya; D. S. Greene; U. A. Shukla ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer ๐ŸŒ English โš– 658 KB

The single-dose pharmacokinetics of nefazodone (NEF) and its metabolites hydroxynefazodone (HO-NEF) and m-chlorophenylpiperazine (mCPP) were examined in 12 healthy younger subjects < 55 years of age (YNG), 12 elderly subjects > 65 years of age (ELD), 12 patients with biopsy proven hepatic cirrhosis

Single intravenous dose and steady-state
Single intravenous dose and steady-state oral dose pharmacokinetics of nicardipine in healthy subjects
โœ John G. Wagner; Teck L. Ling; Edward J. Mroszczak; Donna Freedman; Ann Wu; Bee H ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 617 KB

Nicardipine HCI oral doses (10-40 mg) were administered sequentially to six healthy subjects. For each regimen the capsule dose was administered every 8 hours (q 8 h) for 3 days and the plasma profiles of nicardipine and its pyridine analogue (M5) were determined following the last dose on day 4. St